Vedanta’s Rs 2 lakh crore demerger has sparked renewed interest in its aluminium and power businesses, prompting investors to reassess value creation opportunities. Market focus is shifting towards which segment offers stronger long-term growth, profitability, and sectoral tailwinds as the restructuring reshapes the company’s standalone business prospects and investor positioning.
Molbio Diagnostics shares rally 9% as Jefferies initiates ‘high conviction top pick’ call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600
September 30, 2026